Antimicrobial-resistant pathogens in the 1990s

Annual Review of Medicine

Volumn 47, Issue , 1996, Pages 169-179

  Jacoby, George A ^a  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

Enterococcus; Infection control; Klebsiella pneumoniae; Staphylococcus aureus; Streptococcus pneumoniae

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; CEFACLOR; CEFALEXIN; CEFOTAXIME; CEFPODOXIME; CEFPROZIL; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; IMIPENEM; PENICILLIN G; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; INFECTION CONTROL; KLEBSIELLA PNEUMONIAE; LABORATORY DIAGNOSIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL; REVIEW; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; HUMANS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0029961099     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.47.1.169     Document Type: Review

References (62)

1. Jacoby GA, Archer GL. 1991. New mechanisms of bacterial resistance to antimicrobial agents. N. Engl. J. Med. 324:601-12
2. Appelbaum PC. 1992. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin. Infect. Dis. 15:77-83
3. Spika JS, Facklam RR, Plikaytis BD, et al. 1991. Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979-1987. J. Infect. Dis. 163: 1273-78
4. Thornsberry CI, Brown SD, Yee YC, et al. 1993. Increasing penicillin resistance in Streptococcus pneumoniae in the U.S.: effect on susceptibility to oral cephalosporins. Infect. Med. 10(Suppl. D):15-24
5. Breiman RF, Butler JC, Tenover FC, et al. 1994. Emergence of drug-resistant pneumococcal infections in the United States. J. Am. Med. Assoc. 271:1831-35
6. Zighelboim S, Tomasz A. 1980. Penicillin-binding proteins of multiply antibiotic-resistant South African strains of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 17:434-42
7. Figueiredo AMS, Connor JD, Severin A, et al. 1992. A pneumococcal clinical isolate with high-level resistance to cefotaxime and ceftriaxone. Antimicrob. Agents Chemother. 36:886-89
8. Muñoz R, Dowson CG, Daniels M, et al. 1992. Genetics of resistance to third-generation cephalosporins in clinical isolates of Streptococcus pneumoniae. Mol. Microbiol. 6:2461-65
9. Jabes D, Nachman S, Tomasz A. 1989. Penicillin-binding protein families: evidence for the clonal nature of penicillin resistance in clinical isolates of pneumococci. J. Infect. Dis. 159:16-25
10. Dowson CG, Hutchison A, Brannigan JA, et al. 1989. Horizontal transfer of penicillin-binding protein genes in penicillin-resistant clinical isolates of Streptococcus pneumoniae. Proc. Natl. Acad. Sci. USA 86:8842-66
11. Jorgensen JH, Swenson JM, Tenover FC, et al. 1994. Development of interpretive criteria and quality control limits for broth microdilution and disk diffusion antimicrobial susceptibility testing of Streptococcus pneumoniae. J. Clin. Microbiol. 32: 2448-59
12. Jorgensen JH, Ferraro MJ, McElmeel ML, et al. 1994. Detection of penicillin and extended-spectrum cephalosporin resistance among Streptococcus pneumoniae clinical isolates by use of the E test. J. Clin. Microbiol. 32:159-63
13. Nava JM, Bella F, Garau J, et al. 1994. Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: a population-based study. Clin. Infect. Dis. 19:884-90
14. Klugman KP. 1990. Pneumococcal resistance to antibiotics. Clin. Microbiol. Rev. 3:171-96
15. Friedland IR, McCracken GH Jr. 1994. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N. Engl. J. Med. 331:377-82
16. Friedland IR, Klugman KP. 1992. Failure of chloramphenicol therapy in penicillin-resistant pneumococcal meningitis. Lancet 339:405-8
17. Pankuch GA, Jacobs MR, Appelbaum PC. 1994. Susceptibilities of 200 penicillin-susceptible and -resistant pneumococci to piperacillin, piperacillin-tazobactam, ticarcillin, ticarcillin-clavulanate, ampicillin, ampicillin-sulbactam, ceftazidime, and ceftriaxone. Antimicrob. Agents Chemo ther. 38:2905-7
18. Fung-Tomc JC, Huczko E, Stickle T, et al. 1995. Antibacterial activities of cefprozil compared with those of 13 oral cephems and 3 macrolides. Antimicrob. Agents Chemother. 39:533-38
19. Spangler SK, Jacobs MR, Appelbaum PC. 1994. Susceptibilities of 177 penicillin-susceptible and -resistant pneumococci to FK037, cefpirome, cefepime, ceftriaxone, cefotaxime, ceftazidime, imipenem, biopenem,· meropenem, and vancomycin. Antimicrob. Agents Chemother. 38:898-900
20. Austrian R. 1994. Confronting drug-resistant pneumococci. Ann. Intern. Med. 121: 807-9
21. Grayson ML, Eliopoulos GM, Wennersten CB, et al. 1991. Increasing resistance to ß-lactam antibiotics among clinical isolates of Enterococcus faecium: a 22-year review at one institution. Antimicrob. Agents Chemother. 35:2180-84
22. Murray BE, Mederski-Samoraj BD. 1983. Transferable ß-lactamase: a new mechanism for in vitro penicillin resistance in Streptococcus faecalis. J. Clin. Invest. 72: 1168-71
23. Patterson JE, Zervos MJ. 1990. High-level gentamicin resistance in Enterococcus: microbiology, genetic basis and epidemiology. Rev. Infect. Dis. 12:644-52
24. Murray BE. 1990. The life and times of the enterococcus. Clin. Microbiol. Rev. 3: 46-65
25. Centers for Disease Control and Prevention. 1993. Nosocomial enterococci resistant to vancomycin - United States, 1989-1993. Morbid. Mortal. Wkly Rep. 42: 597-99
26. Arthur M, Courvalin P. 1993. Genetics and mechanisms of glycopeptide resistance in enterococci. Antimicrob. Agents Chemother. 37:1563-71
27. Tenover FC, Swenson JM, O'Hara CM, et al. 1995. Ability of commercial and reference antimicrobial susceptibility testing methods to detect vancomycin resistance in enterococci. J. Clin. Microbiol. 33: 1524-27
28. Reynolds PE, Snaith JA, Maguire AJ, et al. 1994. Analysis of peptidoglycan precursors in vancomycin-resistant Enterococcus gallinarum BM4174. Biochem. J. 301:5-8
29. Fraimow HS, Jungkind DL, Lander DW, et al. 1994. Urinary tract infection with an Enterococcus faecalis isolate that requires vancomycin for growth. Ann. Intern. Med. 121:22-26
30. Norris AH, Reilly JP, Edelstein PH, et al. 1995. Chloramphenicol for the treatment of vancomycin-resistant enterococcal infections. Clin. Infect. Dis. 20:1137-44
31. Sader HS, Pfaller MA, Tenover FC, et al. 1994. Evaluation and characterization of multiresistant Enterococcus faecium from 12 U.S. medical centers. J. Clin. Microbiol. 32:2840-42
32. Jones BL, Ludlam HA, Brown DFJ. 1994. High dose ampicillin for the treatment of high-level aminoglycoside resistant enterococcal endocarditis. J. Antimicrob. Chemother. 33:891-92
33. Hospital Infection Control Practices Advisory Committee. 1995. Recommendations for preventing the spread of vancomycin resistance. Infect. Control Hosp. Epidemiol. 16:105-13
34. Handwerger S, Raucher B, Altarac D, et al. 1993. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clin. Infect. Dis. 16:750-55
35. Livornese LL Jr, Dias S, Samel C, et al. 1992. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann. Intern. Med. 117:112-16
36. Wells CL, Juni BA, Cameron SB, et al. 1995. Stool carriage, clinical isolation, and mortality during an outbreak of vancomycin-resistant enterococci in hospitalized medical and/or surgical patients. Clin. Infect. Dis. 21:45-50
37. Panililio AL, Culver DH, Gaynes RP, et al. 1992. Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991. Infect. Control Hosp. Epidemiol. 13:582-86
38. Layton MC, Hierholzer WJ Jr, Patterson JE. 1995. The evolving epidemiology of methicillin-resistant Staphylococcus aureus at a university hospital. Infect. Control Hosp. Epidemiol. 16:12-17
39. Levine DP, Cushing RD, Jui J, et al. 1982. Community-acquired methicillin-resistant Staphylococcus aureus endocarditis in the Detroit Medical Center. Ann. Intern. Med. 97:330-38
40. Archer GL, Niemeyer DM. 1994. Origin and evolution of DNA associated with resistance to methicillin in staphylococci. Trends Microbiol. 2:343-47
41. Tomasz A, Nachman S, Leaf H. 1991. Stable classes of phenotypic expression in methicillin-resistant clinical isolates of staphylococci. Antimicrob. Agents Chemother. 35:124-29
42. De Lencastre H, Tomasz A. 1994. Reassessment of the number of auxiliary genes essential for expression of high-level methicillin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 38: 2590-98
43. Tomasz A, Drugeon HB, De Lencastre HM, et al. 1989. New mechanism for methicillin resistance in Staphylococcus aureus: clinical isolates that lack the PBP2a gene and contain normal penicillin-binding proteins with modified penicillin-binding capacity. Antimicrob. Agents Chemother. 33:1869-74
44. Barg N, Chambers H, Kernodle D. 1991. Borderline susceptibility to antistaphylococcal penicillins is not conferred exclusively by the hyperproduction of ß-lactamase. Antimicrob. Agents Chemother. 35: 1975-79
45. Hackbarth CJ, Chambers HF. 1989. Methicillin-resistant staphylococci: detection methods and treatment of infections. Antimicrob. Agents Chemother. 33:995-99
46. Shimaoka M, Yoh M, Segawa A, et al. 1994. Development of enzyme-labelled oligonucleotide probe for detection of mecA gene in methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 32: 1866-69
47. Noble WC, Virani Z, Cree RGA. 1992. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12202 to Staphylococcus aureus. FEMS Microbiol. Lett. 93:195-98
48. Yuk JH, Dignani MC, Harris RL, et al. 1991. Minocycline as an alternative antistaphylococcal agent. Rev. Infect. Dis. 13: 1023-24
49. Markowitz N, Quinn EL, Saravolatz LD. 1992. Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection. Ann. Intern. Med. 117:390-98
50. Chambers HF, Kartalija M, Sande M. 1995. Ampicillin, sulbactam, and rifampin combination treatment of experimental methicillin-resistant Staphylococcus aureus endocarditis in rabbits. J. Infect. Dis. 171:897-902
51. Brumfitt W, Hamilton-Miller J. 1989. Methicillin-resistant Staphylococcus aureus. N. Engl. J. Med. 320:1188-96
52. Boyce JM, Jackson MM, Pugliese G, et al. 1994. Methicillin-resistant Staphylococcus aureus (MRSA): a briefing for acute care hospitals and nursing facilities. Infect. Control Hosp. Epidemiol. 15:105-15
53. Fekety R. 1987. The management of the carrier of methicillin-resistant Staphylococcus aureus. Curr. Clin. Top. Infect. Dis. 8:169-80
54. Philippon A, Labia R, Jacoby G. 1989. Extended-spectrum ß-lactamases. Antimicrob. Agents Chemother. 33:1131-36
55. Burwen DR, Banerjee SN, Gaynes RP, et al. 1994. Ceftazidime resistance among selected nosocomial gram-negative bacilli in the United States. J. Infect. Dis. 170: 1622-25
56. Jacoby GA, Medeiros AA. 1991. More extended-spectrum ß-lactamases. Antimicrob. Agents Chemother. 35:1697-704
57. Jacoby GA. 1994. The genetics of extended-spectrum beta-lactamases. Eur. J. Clin. Microbiol. Infect. Dis. 13(Suppl. 1): 2-11
58. Katsanis GP, Spargo J, Ferraro MJ, et al. 1994. Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended-spectrum ß-lactamases. J. Clin. Microbiol. 32:691-96
59. Quinn JP. 1994. Clinical significance of extended-spectrum beta-lactamases. Eur. J. Clin. Microbiol. Infect. Dis. 13(Suppl. 1): 39-42
60. Meyer KS, Urban C, Eagan JA, et al. 1993. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Ann. Intern. Med. 119:353-58
61. De Champs C, Rouby D, Guelon D, et al. 1991. A case-control study of an outbreak of infections caused by Klebsiella pneumoniae strains producing CTX-1 (TEM-3) beta-lactamase. J. Hosp. Infect. 18:5-13
62. IMP among clinically isolated strains of Serratia marcescens. Antimicrob. Agents Chemother. 39:824-29